Split History
ETFs Holding COV »    COV Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Covidien is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. Co.'s reportable segments are as follows: Medical Devices, which includes the sales of advanced and general surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products; and U.S. Medical Supplies, which includes the sale of nursing care products, medical surgical, SharpSafety™ and original equipment manufacturer products. Co.'s medical devices are used primarily by hospitals and ambulatory care centers, as well as alternate site healthcare providers, such as physician offices. According to our COV split history records, COV has had 1 split.
COV split history picture
COV (COV) has 1 split in our COV split history database. The split for COV took place on July 01, 2013. This was a 1128 for 1000 split, meaning for each 1000 shares of COV owned pre-split, the shareholder now owned 1128 shares. For example, a 1000 share position pre-split, became a 1128 share position following the split.

When a company such as COV splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.

Looking at the COV split history from start to finish, an original position size of 1000 shares would have turned into 1128 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into COV shares, starting with a $10,000 purchase of COV, presented on a split-history-adjusted basis factoring in the complete COV split history. COV split adjusted history picture

Growth of $10,000.00
With Dividends Reinvested

Start date: 12/10/2012
End date: 01/26/2015
Start price/share: $51.27
End price/share: $106.71
Starting shares: 195.05
Ending shares: 202.58
Dividends reinvested/share: $2.72
Total return: 116.17%
Average Annual Total Return: 43.64%
Starting investment: $10,000.00
Ending investment: $21,617.36
Years: 2.13
Growth of $10,000.00
Without Dividends Reinvested

Start date: 12/10/2012
End date: 01/26/2015
Start price/share: $51.27
End price/share: $106.71
Dividends collected/share: $2.72
Total return: 113.44%
Average Annual Total Return: 42.78%
Starting investment: $10,000.00
Ending investment: $21,342.77
Years: 2.13
Date Ratio
07/01/20131128 for 1000
COV is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

CRDC Split History
CRIS Split History
CRMD Split History
CRTX Split History
CRVL Split History
CRY Split History
CSBR Split History
CSII Split History
CSU Split History
CTIC Split History

Email EnvelopeFree COV Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Eloxx Pharmaceuticals, Inc. (ELOX)
Baudax Bio, Inc. (BXRX)
Petros Pharmaceuticals, Inc. (PTPI)
Tuesday Morning Corporation (TUEM)
DURECT Corporation (DRRX)
CNS Pharmaceuticals, Inc. (CNSP)
Astrotech Corporation (ASTC)
SuperCom (SPCB)
Qualigen Therapeutics, Inc. (QLGN)
MicroSectors Oil & Gas Exploration & Production -3X Inverse Leveraged ETNs due June 28, 2041 (OILD)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

COV Insider Buying

COV Split History | www.SplitHistory.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.